NEWGEN2024-10-012024-12-31 NEWGEN2024-10-012024-12-31 NEWGEN2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member NEWGEN2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member NEWGEN2024-12-31 NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue01Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue02Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue03Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue04Member NEWGEN2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue01Member NEWGEN2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue02Member NEWGEN2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue03Member NEWGEN2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue04Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults01Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults02Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults03Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults04Member NEWGEN2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults01Member NEWGEN2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults02Member NEWGEN2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults03Member NEWGEN2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults04Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets01Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets02Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets03Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets04Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member NEWGEN2024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member NEWGEN2024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities03Member NEWGEN2024-12-31in-bse-fin:OneReportableSegmentLiabilities03Member NEWGEN2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities04Member NEWGEN2024-12-31in-bse-fin:OneReportableSegmentLiabilities04Member NEWGEN2024-10-012024-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member NEWGEN2024-10-012024-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member NEWGEN2024-10-012024-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member NEWGEN2024-10-012024-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member NEWGEN2024-10-012024-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member NEWGEN2024-10-012024-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 540900 NEWGEN NOTLISTED Newgen Software Technologies Limited Equity 2024-04-01 2025-03-31 2025-01-20 2025-01-13 INR Lakhs Third quarter 12:40:00 13:10:00 2025-01-20 2025-01-20 Not applicable Geographical 2024-10-01 2024-12-31 Unaudited Consolidated 3811126000.00 83769000.00 3894895000.00 0.00 0.00 0.00 1882468000.00 14047000.00 86631000.00 845442000.00 2828588000.00 1066307000.00 0.00 1066307000.00 267694000.00 -91404000.00 176290000.00 0.00 890017000.00 0.00 0.00 0.00 0.00 890017000.00 -1256000.00 888761000.00 890017000.00 0.00 888761000.00 0.00 1399554000.00 10 6.36 6.16 0.00 0.00 6.36 6.16 Statement of Standalone and Consolidated Financial Results of Newgen Software Technologies Limited for the quarter and nine month ended 31 December 2024. Notes: 1.The above financial results for the quarter and nine month ended 31 December 2024 were reviewed by the Audit Committee in the meeting held on 20 January 2025 and approved by the Board of Directors in their meeting held on 20 January 2025. Standalone and Consolidated financial results of the Company for the quarter and nine month ended 31 December 2024 are prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013 and relevant rules thereunder. The company has complied with the guidelines issued by Securities & Exchange Board of India (SEBI) to the extent applicable. 2.The auditors have carried out limited review of Standalone and Consolidated results of the Company for the quarter and nine month ended 31 December 2024. There are no qualifications in the Auditor's review report on these financial results. 3.The Board of Directors in their meeting held on 30 April 2024 had recommended a dividend of INR 4.00 per equity share ( on face value of INR 10/- each on the expanded capital base post bonus issue of 1:1) for the financial year ended 31 March 2024 which was approved by the shareholder at the Annual General Meeting held on 25 July 2024. The dividend was paid on 2 August 2024. 4.Pursuant to the Board approval on 27 November 2023 and shareholder's approval on 2 January 2024, through Postal Ballot, the Company has allotted 7,00,69,401 bonus shares of INR 10/- each (fully paid up) on 13 January 2024 to the eligible members of the Company whose names appear in the Register of Members of the Company /List of Beneficial Owners as on the Record Date i.e., 12 January 2024 in the ratio of 1:1. The said bonus shares shall rank pari passu in all respects with the existing equity shares of the Company, including dividend. As a result of the bonus issue, the paid-up capital of the Company has increased to INR 14,013.88 lakhs from INR 7,006.94 lakhs. Consequent to the above increase in paid-up capital, the earnings per share (Basic and Diluted) have been adjusted for the quarter and nine month ended 31 December 2023. 5.During the quarter ended 31 December 2024, the Nomination & Remuneration Committee has granted 5,30,100 options under Newgen ESOP Scheme 2022 to its employees on 15 October 2024. Previous periods/years figures have been regrouped/reclassified wherever necessary to correspond with the current period/year classification/disclosure, which are not considered material to these financial results. For and on behalf of the Board of Directors of Newgen Software Technologies Limited Diwakar Nigam Chairman & Managing Director DIN: 00263222 Place: New Delhi Date: 20 January 2025 Geographical 2024-04-01 2024-12-31 Unaudited Consolidated 10569894000.00 494576000.00 11064470000.00 0.00 0.00 0.00 5469586000.00 33593000.00 243960000.00 2710364000.00 8457503000.00 2606967000.00 0.00 2606967000.00 654870000.00 -116935000.00 537935000.00 0.00 2069032000.00 0.00 0.00 0.00 0.00 2069032000.00 16173000.00 2085205000.00 2069032000.00 0.00 2085205000.00 0.00 1399554000.00 10 14.79 14.31 0.00 0.00 14.79 14.31 Other Expenses 845442000.00 Other Expenses 2710364000.00 APAC 608061000.00 EMEA 1189479000.00 India 1220126000.00 USA 793460000.00 APAC 1612740000.00 EMEA 3426789000.00 India 3250474000.00 USA 2279891000.00 3811126000.00 10569894000.00 0.00 0.00 3811126000.00 10569894000.00 APAC 273901000.00 EMEA 456831000.00 India 181405000.00 USA 176694000.00 APAC 532250000.00 EMEA 994552000.00 India 448649000.00 USA 430896000.00 1088831000.00 2406347000.00 14047000.00 33593000.00 8477000.00 Note :- a) Unallocated assets, liabilities, revenue and expenses: Certain assets, liabilities, revenue and expenses are not specifically allocable to individual segments as the underlying services are used interchangeably. The Company believes that it is not practicable to provide segment disclosures relating to such assets, liabilities, revenue and expenses and accordingly such assets, liabilities, revenue and expenses are separately disclosed as ‘unallocated’. -234213000.00 1066307000.00 2606967000.00 APAC 1101328000.00 EMEA 2369066000.00 India 2278491000.00 USA 1831249000.00 7580134000.00 10518121000.00 18098255000.00 APAC 478496000.00 EMEA 789020000.00 India 1187560000.00 USA 764738000.00 3219814000.00 915676000.00 4135490000.00 Re-measurement losses on defined benefit plans -7576000.00 Re-measurement losses on defined benefit plans -30301000.00 -7576000.00 -30301000.00 -2647000.00 -10588000.00 Debt instruments through other comprehensive income - net change in fair value -5781000.00 Exchange differences on translation of foreign operations 8107000.00 Debt instruments through other comprehensive income - net change in fair value -11160000.00 Exchange differences on translation of foreign operations 44446000.00 2326000.00 33286000.00 -1347000.00 -2600000.00